Week In Review: WuXi Sells Stake In CMO Subsidiary; Lists On China OTC Exchange
April 04, 2015 at 21:41 PM EDT
WuXi PharmaTech (NYSE: WX) sold a 5.55% stake in SynTheAll Pharma, its chemical drug contract manufacturing subsidiary, to management of STA and WuXi for $28 million.
